Insulet (PODD) Total Liabilities (2010 - 2026)

Insulet has reported Total Liabilities for 17 years, with the latest figure at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 22.96% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (down 22.96% YoY), and the FY2025 full-year result was $1.7 billion, down 10.71% from the prior year.
• Total Liabilities for Q1 2026 stood at $1.7 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Total Liabilities was $2.2 billion in Q1 2025, with the low at $1.6 billion in Q1 2022.
• Historically, Total Liabilities has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2023.
• Annual changes were most pronounced in 2022 — Total Liabilities rose 29.3% — and 2026, when it retreated 22.96%.
• Insulet's Total Liabilities stood at $1.8 billion in 2022, then gained by 4.55% to $1.9 billion in 2023, then climbed by 1.11% to $1.9 billion in 2024, then declined by 10.71% to $1.7 billion in 2025, then grew by 0.56% to $1.7 billion in 2026.
• The last three Total Liabilities figures came in at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.